Literature DB >> 10532448

Age-related macular degeneration and antioxidant status in the POLA study. POLA Study Group. Pathologies Oculaires Liées à l'Age.

C Delcourt1, J P Cristol, F Tessier, C L Léger, B Descomps, L Papoz.   

Abstract

OBJECTIVE: To give the levels of antioxidant nutrients in relation to age-related macular degeneration (AMD).
METHODS: Pathologies Oculaires Liees a l'Age is a population-based study on cataract and AMD and their risk factors, carried out on 2584 inhabitants of Sete, France. Age-related macular degeneration was defined by findings from fundus photographs according to an international classification. Biological measurements were taken from fasting blood samples.
RESULTS: After multivariate adjustment, plasma alpha-to-copherol levels showed a weak negative association with late AMD (P = .07). Lipid-standardized plasma alpha-tocopherol levels showed a significant negative association with late AMD (P= .003): the risk of late AMD was reduced by 82% in the highest quintile compared with the lowest. Similarly, lipid-standardized plasma alpha-tocopherol levels were inversely associated with early signs of AMD (odds ratio, 0.72 [95% confidence interval, 0.53-0.98]; P=.04). No associations were found with plasma retinol and ascorbic acid levels or with red blood cell glutathione values. COMMENT: These results suggest that vitamin E may provide protection against AMD. Only randomized interventional studies could prove the protective effect of vitamin E on AMD.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10532448     DOI: 10.1001/archopht.117.10.1384

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  25 in total

Review 1.  Epidemiology of age-related maculopathy: a review.

Authors:  Redmer van Leeuwen; Caroline C W Klaver; Johannes R Vingerling; Albert Hofman; Paulus T V M de Jong
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

2.  Prevention of age related macular degeneration.

Authors:  Nigel F Hall; Catharine R Gale
Journal:  BMJ       Date:  2002-07-06

3.  Macular pigment density in healthy subjects quantified with a modified confocal scanning laser ophthalmoscope.

Authors:  Henrike Wüstemeyer; Andreas Moessner; Cornelia Jahn; Sebastian Wolf
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-07-17       Impact factor: 3.117

4.  Macular pigment density in age-related maculopathy.

Authors:  Cornelia Jahn; Henrike Wüstemeyer; Christian Brinkmann; Sandra Trautmann; Andreas Mössner; Sebastian Wolf
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-10-02       Impact factor: 3.117

5.  ["Do you have a remedy for macular degeneration?" A field study about the advice given on dietary supplementation in 60 German pharmacies].

Authors:  F Ziemssen; M Warga; K U Bartz-Schmidt; H Wilhelm
Journal:  Ophthalmologe       Date:  2005-07       Impact factor: 1.059

6.  Macular pigment optical density in the elderly: findings in a large biracial Midsouth population sample.

Authors:  Alessandro Iannaccone; Marco Mura; Kevin T Gallaher; Elizabeth J Johnson; William Andrew Todd; Emily Kenyon; Tarsha L Harris; Tamara Harris; Suzanne Satterfield; Karen C Johnson; Stephen B Kritchevsky
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-04       Impact factor: 4.799

7.  Risk factors for age-related maculopathy.

Authors:  Paul P Connell; Pearse A Keane; Evelyn C O'Neill; Rasha W Altaie; Edward Loane; Kumari Neelam; John M Nolan; Stephen Beatty
Journal:  J Ophthalmol       Date:  2009-09-06       Impact factor: 1.909

Review 8.  [Lutein and antioxidants in the prevention of age-related macular degeneration].

Authors:  M Rehak; E Fric; P Wiedemann
Journal:  Ophthalmologe       Date:  2008-01       Impact factor: 1.059

9.  Vitamin E supplementation and macular degeneration: randomised controlled trial.

Authors:  Hugh R Taylor; Gabriella Tikellis; Luba D Robman; Catherine A McCarty; John J McNeil
Journal:  BMJ       Date:  2002-07-06

10.  rs5888 variant of SCARB1 gene is a possible susceptibility factor for age-related macular degeneration.

Authors:  Jennyfer Zerbib; Johanna M Seddon; Florence Richard; Robyn Reynolds; Nicolas Leveziel; Pascale Benlian; Patrick Borel; Josué Feingold; Arnold Munnich; Gisèle Soubrane; Josseline Kaplan; Jean-Michel Rozet; Eric H Souied
Journal:  PLoS One       Date:  2009-10-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.